Kramer Levin Launches Public Alternative Funds Blog
Electronic Discovery Update: Spring 2013
Mr. Rhoads’ practice focuses on the litigation of intellectual property matters at the trial and appellate court levels and the strategic development and management of patent, trademark, trade secret and copyright portfolios.
Mr. Rhoads’ litigation experience includes obtaining favorable resolutions in several pharmaceutical cases involving accused infringers (e.g., Purdue v. Endo, Bracco v. Amersham and Bracco v. Zambon) and patentees, as well as in litigations against the Food and Drug Administration and the United States Patent and Trademark Office. Mr. Rhoads has been involved in dozens of Hatch-Waxman Act based disputes, representing ANDA filers as well as patent holders.
His practice also involves false advertising cases between pharmaceutical companies, including as lead trial counsel in a 39 day trial between Bracco and Amersham (now GE), which resulted in significant monetary and injunctive relief for his client.
Mr. Rhoads also has been involved in the successful litigation of several cases concerning electronic devices (e.g., GTE v. Nokia) and medical devices.
Mr. Rhoads has been involved in several major patent interference proceedings and has developed strategies that relate to using patent prosecution, interferences, litigation and licensing to maximize the value of intellectual property. This has included obtaining worldwide patent and trademark protection for numerous clients in all fields of technology.
Mr. Rhoads has developed strategies for several corporations to enter into markets for the first time, providing counseling for the corporations on infringement, validity and enforceability matters and seeking and negotiating intellectual property licenses to gain freedom of operation. This also has involved the negotiation and formation of mergers, acquisitions and joint ventures as well as the licensing of technology.
Mr. Rhoads has authored several articles relating to intellectual property, including articles on patent reform, biotechnology and patent law, the process patent amendment act, interference proceedings, patent procurement and enforcement in China, and intellectual property licensing.